Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Aeterna Zentaris Inc.

NEW YORK, NY, April 23, 2015 /CNW Telbec/ - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO) on Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ). The full 52-page report is available on Crystal Research Associates' website at www.crystalra.com as well as on Aeterna Zentaris' website at www.aezsinc.com.

Aeterna Zentaris ("Aeterna" or "the Company") is transitioning into a specialty biopharmaceutical company in oncology, endocrinology, and women's health. With a focus on establishing revenues and profitability while optimizing resources to reduce its burn rate, the Company co-promotes a non-patch estrogen replacement therapy, EstroGel®, in specific U.S. markets with partner, Ascend Therapeutics ("Ascend"). As well, Aeterna holds a pipeline of candidates in varying stages of development and is working to acquire, in-license, or co-promote other commercial compounds.

The Company's most advanced wholly owned clinical candidate, zoptarelin doxorubicin (doxorubicin peptide conjugate targeting LHRH receptor–expressing tumors), is in a Phase 3 trial in advanced, recurrent, or metastatic endometrial cancer—a disease for which patients typically have a poor prognosis and there is no approved systemic therapy. Aeterna's pipeline further includes Macrilen™, a drug for the evaluation of Adult Growth Hormone Deficiency (AGHD), for which the Company intends to initiate a confirmatory Phase 3 program, as well as other compounds in oncology, as the Company works to pursue strategic initiatives consistent with becoming a commercially operating specialty biopharmaceutical company.

Be the first to hear about Crystal Research's new report releases and upcoming media coverage. Follow us at http://www.crystalra.com/blog for more coverage.

About Crystal Research Associates, LLC

For the past decade, Crystal Research Associates, LLC (www.crystalra.com) has successfully articulated the exceptional stories of small- and mid-cap companies to the Wall Street investor community. Our methods are well-established and diverse, from compiling and disseminating objective, factual information for both institutional and retail investor audiences to capitalizing on our expansive line of targeted distribution channels, which include industry-leading financial data and information providers. Our distribution efforts are accompanied by the use of prominent social media channels and by strategic and targeted appearances on national news programs and print media.

Crystal Research Associates is led by Wall Street veterans, Jeffrey Kraws and Karen Goldfarb. Together, Kraws and Goldfarb have built a unique business model, capitalizing on decades of experience as an award-winning sell-side analyst team to produce institutional-quality industry and market research in a manner that is easily understood by investors and consumers. Our firm's approach has been proven successful over the years as our products are published and available on Bloomberg, Thomson Reuters/First Call, Capital IQ, FactSet, Yahoo! Finance, and scores of other popular forums.

Forward-Looking Safe Harbor Statement

Statements in this news release regarding future financial and operating results, potential applications of the Company's technology, opportunities for the Company, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including limited operating history, need for future capital, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company's periodic news and reports. Crystal Research Associates' compensation is a cash amount of thirty-nine thousand U.S. dollars for its services in creating this report and other communications products.

These statements, and other forward-looking statements, are not guarantees of future performance and involve risks and uncertainties. Crystal Research Associates assumes no obligation to update any of the forward-looking statements in this release.

 

SOURCE Aeterna Zentaris Inc.

For further information: Jeffrey J. Kraws/Karen B. Goldfarb, Crystal Research Associates, LLC, P: (609) 306-2274, F: (609) 395-9339

RELATED LINKS
http://www.aezsinc.com

Organization Profile

Aeterna Zentaris Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890